Angiotensin II destabilizes coronary plaques in watanabe heritable hyperlipidemic rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 5, 2016, Pages 810-816

  Li, Shen ^a   Wang, Yan Ning ^a   Niimi, Manabu ^a   Ning, Bo ^a   Chen, Yajie ^a   Kang, Dedong ^a   Waqar, Ahmed Bilal ^a   Wang, Ziyun ^a   Yu, Qi ^a   Liu, Enqi ^b   Zhang, Jifeng ^d   Shiomi, Masashi ^c   Chen, Y Eugene ^d   Fan, Jianglin ^a,e  

^a UNIVERSITY OF YAMANASHI   (Japan)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c KOBE UNIVERSITY   (Japan)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e XI'AN MEDICAL UNIVERSITY   (China)

Author keywords

acute coronary syndrome; angiotensin II; hypercholesterolemia; myocardial infarction; thrombosis

Indexed keywords

ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MACROPHAGE ELASTASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPNEA; FAMILIAL HYPERCHOLESTEROLEMIA; GENE EXPRESSION; HEART INFARCTION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MORTALITY RATE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; WATANABE HERITABLE HYPERLIPIDEMIC RABBIT; ANIMAL; ATHEROSCLEROTIC PLAQUE; BLOOD; CHEMICALLY INDUCED; COMPLICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE MODEL; DRUG EFFECTS; GENETIC PREDISPOSITION; GENETICS; HEREDITY; IMPLANTABLE INFUSION PUMP; PATHOLOGY; PHENOTYPE; RABBITS AND HARES; SUBCUTANEOUS DRUG ADMINISTRATION; TIME FACTOR;

ANGIOTENSIN II; ANIMALS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HYPERLIPOPROTEINEMIA TYPE II; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, SUBCUTANEOUS; MYOCARDIAL INFARCTION; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; RABBITS; TIME FACTORS;

EID: 84961221463     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306871     Document Type: Article

References (41)

1. Kim S, Iwao H, Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000 52 11 34
2. Benigni A, Cassis P, Remuzzi G, Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2010 2 247 257. doi: 10.1002/emmm.201000080
3. Gavras I, Gavras H, Angiotensin II as a cardiovascular risk factor. J Hum Hypertens 2002 16(suppl 2) S2 S6. doi: 10.1038/sj.jhh.1001392
4. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM, Renin-Angiotensin system and cardiovascular risk. Lancet 2007 369 1208 1219. doi: 10.1016/S0140-6736(07)60242-6
5. da Silva AR, Fraga-Silva RA, Stergiopulos N, Montecucco F, Mach F, Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis. Eur J Clin Invest 2015 45 274 287. doi: 10.1111/eci.12401
6. Potter DD, Sobey CG, Tompkins PK, Rossen JD, Heistad DD, Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation 1998 98 800 807
7. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H, Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000 101 1372 1378
8. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH, Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991 324 1098 1104. doi: 10.1056/NEJM199104183241605
9. Chobanian AV, Haudenschild CC, Nickerson C, Drago R, Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension 1990 15 327 331
10. Campbell JH, Fennessy P, Campbell GR, Effect of perindopril on the development of atherosclerosis in the cholesterol-fed rabbit. Clin Exp Pharmacol Physiol Suppl 1992 19 13 17
11. Schuh JR, Blehm DJ, Frierdich GE, McMahon EG, Blaine EH, Differential effects of renin-Angiotensin system blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest 1993 91 1453 1458. doi: 10.1172/JCI116350
12. Strawn WB, Chappell MC, Dean RH, Kivlighn S, Ferrario CM, Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 2000 101 1586 1593
13. Strauss MH, Hall AS, Angiotensin receptor blockers may increase risk of myocardial infarction: unraveling the ARB-MI paradox. Circulation 2006 114 838 854. doi: 10.1161/CIRCULATIONAHA.105.594986
14. Tsuyuki RT, McDonald MA, Angiotensin receptor blockers do not increase risk of myocardial infarction. Circulation 2006 114 855 860. doi: 10.1161/CIRCULATIONAHA.105.594978
15. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C, Telmisartan, ramipril, or both in patients at high risk for vascular events. The N Engl J Med 2008 358 1547 1559
16. Kruzliak P, Kovacova G, Pechanova O, Balogh S, Association between angiotensin II type 1 receptor polymorphism and sudden cardiac death in myocardial infarction. Dis Markers 2013 35 287 293. doi: 10.1155/2013/731609
17. Rice GI, Foy CA, Grant PJ, Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease. Cardiovasc Res 1999 41 746 753
18. Xu M, Sham P, Ye Z, Lindpaintner K, He L, A1166C genetic variation of the angiotensin II type I receptor gene and susceptibility to coronary heart disease: collaborative of 53 studies with 20,435 cases and 23,674 controls. Atherosclerosis 2010 213 191 199. doi: 10.1016/j.atherosclerosis.2010.07.046
19. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994 90 669 676
20. Daugherty A, Manning MW, Cassis LA, Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000 105 1605 1612. doi: 10.1172/JCI7818
21. Weiss D, Kools JJ, Taylor WR, Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 2001 103 448 454
22. Sugiyama F, Haraoka S, Watanabe T, Shiota N, Taniguchi K, Ueno Y, Tanimoto K, Murakami K, Fukamizu A, Yagami K, Acceleration of atherosclerotic lesions in transgenic mice with hypertension by the activated renin-Angiotensin system. Lab Invest 1997 76 835 842
23. Alderman MH, Is there a link between the circulating renin-Angiotensin system and coronary disease? A buoyant view. Heart 1996 76 3 Suppl 3 18 22
24. Weiss D, Sorescu D, Taylor WR, Angiotensin II and atherosclerosis. Am J Cardiol 2001 87 8A 25C 32C
25. Li S, Liang J, Niimi M, Bilal Waqar A, Kang D, Koike T, Wang Y, Shiomi M, Fan J, Probucol suppresses macrophage infiltration and MMP expression in atherosclerotic plaques of WHHL rabbits. J Atheroscler Thromb 2014 21 648 658
26. Liang J, Liu E, Yu Y, Kitajima S, Koike T, Jin Y, Morimoto M, Hatakeyama K, Asada Y, Watanabe T, Sasaguri Y, Watanabe S, Fan J, Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 2006 113 1993 2001. doi: 10.1161/CIRCULATIONAHA.105.596031
27. Shah PK, Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion. Prog Cardiovasc Dis 2002 44 357 368
28. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM, Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler Thromb Vasc Biol 2000 20 2587 2592
29. Bond AR, Jackson CL, The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture. J Biomed Biotechnol 2011 2011 379069. doi: 10.1155/2011/379069
30. Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, Tofler GH, Muller JE, Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation 1995 91 776 784
31. Caligiuri G, Levy B, Pernow J, Thorén P, Hansson GK, Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc Natl Acad Sci U S A 1999 96 6920 6924
32. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M, Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 2002 90 270 276
33. Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P, Evidence for increased collagenolysis by interstitial collagenases-1 and-3 in vulnerable human atheromatous plaques. Circulation 1999 99 2503 2509
34. Galis ZS, Sukhova GK, Kranzhöfer R, Clark S, Libby P, Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 1995 92 402 406
35. Ridker PM, Gaboury CL, Conlin PR, Seely EW, Williams GH, Vaughan DE, Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-Angiotensin system and fibrinolytic function. Circulation 1993 87 1969 1973
36. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW, Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994 74 1141 1148
37. Schmidt-Ott KM, Kagiyama S, Phillips MI, The multiple actions of angiotensin II in atherosclerosis. Regul Pept 2000 93 65 77
38. Mügge A, The role of reactive oxygen species in atherosclerosis. Z Kardiol 1998 87 851 864
39. Gavras H, Kremer D, Brown JJ, Gray B, Lever AF, MacAdam RF, medina A, Morton JJ, Robertson JI, Angiotensin-And norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J 1975 89 321 332
40. Gavras H, Lever AF, Brown JJ, Macadam RF, Robertson JI, Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet 1971 2 19 22
41. Shiomi M, Ishida T, Kobayashi T, Nitta N, Sonoda A, Yamada S, Koike T, Kuniyoshi N, Murata K, Hirata K, Ito T, Libby P, Vasospasm of atherosclerotic coronary arteries precipitates acute ischemic myocardial damage in myocardial infarction-prone strain of the Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 2013 33 2518 2523. doi: 10.1161/ATVBAHA.113.301303